SEARCH RESULTS FOR: "Tag: BLUE"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023(1)
2022(1)
2021(1)
2020(1)
2019(2)
2018(5)
2017(11)
2016(7)
2015(14)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(1)
Analyst Update(10)
Analyst Upgrades(3)
Buzz Stocks(8)
Ezines(1)
General(3)
Intraday Option Activity(2)
Market Recap(1)
Midday Market Check(6)
Opening View(3)
Stock Market News(2)
Stocks On the Move(7)
Trade Postmortem(1)
Unusual Trading Activity(2)

12/8/2023 10:47 AM
Bluebird Bio Inc (NASDAQ:BLUE) stock is enjoying a boost today, after an upgrade from Morgan Stanley to "equal-weight" from "underweight," with a price-target hike to $7.00 from $3.00. The firm antic...
9/19/2022 10:32 AM
Bluebird Bio Inc (NASDAQ:BLUE) is in the spotlight today, after the U.S. Food and Drug Administration (FDA) approved SKYSONA, its gene therapy for the treatment of Cerebral Adrenoleukodystrophy (CALD)...
7/9/2021 10:36 AM
The shares of bluebird bio Inc (NASDAQ:BLUE) are higher today, on news that the biotech company is lifting its voluntary marketing suspension of its gene therapy treatment, Zynteglo. The drug, which ...
2/19/2020 1:53 PM
Gene therapy developer bluebird bio Inc (NASDAQ:BLUE) is down 9% at $80.64 in afternoon trading, sinking after weak fourth-quarter results and news its blood disorder therapy drug Zynteglo applicatio...
12/10/2019 12:03 PM
It's another day of weak price action for stocks on Wall Street, with traders mostly holding tight ahead of tomorrow's Fed decision. Ahead of the opening bell, it looked as though apparent headway i...